The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: FOXG1 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_005249.5(FOXG1):c.670G>A (p.Gly224Ser)

CA234034

167092 (ClinVar)

Gene: FOXG1
Condition: FOXG1 disorder
Inheritance Mode: Autosomal dominant inheritance
UUID: 19e564c0-0f26-42d4-8dcc-709b295fda70
Approved on: 2024-12-18
Published on: 2025-03-26

HGVS expressions

NM_005249.5:c.670G>A
NM_005249.5(FOXG1):c.670G>A (p.Gly224Ser)
NC_000014.9:g.28767949G>A
CM000676.2:g.28767949G>A
NC_000014.8:g.29237155G>A
CM000676.1:g.29237155G>A
NC_000014.7:g.28306906G>A
NG_009367.1:g.5869G>A
ENST00000706482.1:c.670G>A
ENST00000313071.7:c.670G>A
ENST00000313071.6:c.670G>A
NM_005249.4:c.670G>A
More

Likely Pathogenic

Met criteria codes 6
PP3 PM1 PM6 PS4_Moderate PM2_Supporting PS3_Supporting
Not Met criteria codes 14
BA1 BS4 BS3 BS1 BS2 BP5 BP2 BP4 PS2 PS1 PP4 PP1 PM3 PM5

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for FOXG1 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Gly224Ser variant occurs in the well-characterized Forkhead functional domain of the FOXG1 gene (PMID: 18571142, 28661489) (PM1). The p.Gly224Ser variant in FOXG1 occurs in the de novo state (biological parentage unconfirmed) in an individual with gross motor delay and infantile spasms (Internal database - GeneDx) (PM6). Functional study has shown that this variant impacts protein function (PMID: 35163265) (PS3_supporting). Computational prediction analysis tools suggest a deleterious impact; however, this information does not predict clinical significance on its own (PP3). The p.Gly224Ser variant in FOXG1 is absent from gnomAD v4.1.0 (PM2_Supporting). The p.Gly224Ser variant has been observed in 3 individuals with neurodevelopmental disease (PMID: 30533527, Internal database - GeneDx, Internal database - University of Chicago) (PS4_moderate). In summary, this variant meets the criteria to be classified as Likely Pathogenic based on ACMG/AMP criteria (PM1, PM6, PS3_supporting, PP3_supporting, PM2_supporting, PS4_moderate). (FOXG1 specification v3.0.0; approved on 12/18/2024)
Met criteria codes
PP3
Computational prediction analysis tools suggest a deleterious impact; however, this information does not predict clinical significance on its own (PP3).
PM1
The p.Gly224Ser variant occurs in the well-characterized Forkhead functional domain of the FOXG1 gene (PMID: 18571142, 28661489).
PM6
The p.Gly224Ser variant in FOXG1 occurs in the de novo state (biological parentage unconfirmed) in an individual with gross motor delay and infantile spasms (GeneDx internal database).
PS4_Moderate
The p.Gly224Ser variant has been observed in 3 individuals with neurodevelopmental disease (PMID: 30533527, GeneDx internal database, University of Chicago internal database) (PS4_moderate).
PM2_Supporting
The p.Gly224Ser variant in FOXG1 is absent from gnomAD v4.1.0 (PM2_Supporting).
PS3_Supporting
Functional study has shown that this variant impacts protein function (PMID 35163265) (PS3_supporting).

Not Met criteria codes
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
A missense variant in this codon, c.671G>A (p.Gly224Asp), was reported in ClinVar as Likely Pathogenic, as well as in PMID: 29655203 but there is insufficient evidence to classify as Pathogenic.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.